Security key
426897104
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897104
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 29,123,952
- Total 13F shares
- 280,899
- Share change
- +84,797
- Total reported value
- $138,008
- Price per share
- $0.44
- Number of holders
- 7
- Value change
- +$18,852
- Number of buys
- 3
- Number of sells
- 3
Report period
Q4 2022
Institutions
7
Top holders
8
HEPA full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897104
Recent filing periods:
Top shareholders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
3,308,523
|
$1,672,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
1,592,781
|
$805,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
658,110
|
$332,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
313,500
|
$158,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.8%
|
232,100
|
$117,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.57%
|
165,190
|
$84,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.54%
|
158,214
|
$80,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
132,059
|
$67,000 | — | 30 Sep 2022 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.37%
|
107,915
|
$54,518 | — | 30 Sep 2022 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.3%
|
87,541
|
$44,000 | — | 30 Sep 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.23%
|
67,802
|
$34,000 | — | 30 Sep 2022 | |
| McAdam, LLC |
13F
|
Company |
0.21%
|
62,169
|
$31,000 | — | 30 Sep 2022 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.2%
|
57,534
|
$29,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
31,535
|
$16,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.11%
|
31,091
|
$16,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.1%
|
30,100
|
$15,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.09%
|
26,236
|
$13,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
21,030
|
$11,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
19,966
|
$10,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
16,421
|
$8,000 | — | 30 Sep 2022 | |
| Cetera Investment Advisers |
13F
|
Company |
0.04%
|
11,273
|
$6,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
10,800
|
$5,000 | — | 30 Sep 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
3,500
|
$1,768 | — | 30 Sep 2022 | |
| BENJAMIN F. EDWARDS & COMPANY, INC. |
13F
|
Company |
0%
|
1,001
|
$1,000 | — | 30 Sep 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1
|
$1,000 | — | 30 Sep 2022 | |
| Cavan John T. |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
1,581,060
|
— | — | 18 May 2021 | |
| Arnold Lippa |
3/4/5
|
Director |
—
class O/S missing
|
291,110
|
— | — | 18 May 2021 | |
| Thomas Adams PhD |
3/4/5
|
Director |
—
class O/S missing
|
291,050
|
— | — | 18 May 2021 |
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q4 2022
As of 31 Dec 2022,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
280,899 shares.
The largest 8 holders included
ENVESTNET ASSET MANAGEMENT INC, McAdam, LLC, Amplius Wealth Advisors, LLC, Federation des caisses Desjardins du Quebec, ADVISOR GROUP HOLDINGS, INC., BARCLAYS PLC, SIGNATUREFD, LLC, and IFP Advisors, Inc.
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
25
Q4 2022 holders
7
Holder diff
-18
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.